Free Trial

Dolby Laboratories (NYSE:DLB) Releases FY 2025 Earnings Guidance

Dolby Laboratories logo with Consumer Discretionary background

Key Points

  • Dolby Laboratories updated its FY 2025 earnings guidance, projecting an EPS of $3.880-4.030 and revenue of $1.3 billion-$1.4 billion.
  • Several analysts reaffirmed their ratings on Dolby, with Barrington Research setting a price target of $100.00 and Tigress Financial offering a target of $112.00.
  • The company has reported a dividend yield of 1.8%, reflecting a quarterly dividend payment of $0.33 per share for shareholders.
  • Want stock alerts on Dolby Laboratories? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Dolby Laboratories (NYSE:DLB - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 3.880-4.030 for the period, compared to the consensus earnings per share estimate of 3.970. The company issued revenue guidance of $1.3 billion-$1.4 billion, compared to the consensus revenue estimate of $1.3 billion. Dolby Laboratories also updated its Q4 2025 guidance to 0.610-0.760 EPS.

Dolby Laboratories Stock Performance

NYSE:DLB traded up $1.48 during trading hours on Monday, hitting $71.57. 59,830 shares of the company's stock traded hands, compared to its average volume of 427,291. The firm has a market cap of $6.88 billion, a P/E ratio of 26.23 and a beta of 0.91. Dolby Laboratories has a twelve month low of $66.35 and a twelve month high of $89.66. The stock's fifty day moving average price is $74.92 and its two-hundred day moving average price is $77.54.

Dolby Laboratories (NYSE:DLB - Get Free Report) last issued its earnings results on Thursday, July 31st. The electronics maker reported $0.78 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.06. Dolby Laboratories had a return on equity of 11.52% and a net margin of 19.62%. The company had revenue of $315.55 million for the quarter, compared to analyst estimates of $305.23 million. During the same period in the prior year, the firm posted $0.71 EPS. The business's revenue was up 9.2% compared to the same quarter last year. On average, equities research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th will be given a $0.33 dividend. This represents a $1.32 annualized dividend and a yield of 1.8%. The ex-dividend date of this dividend is Tuesday, August 12th. Dolby Laboratories's dividend payout ratio is presently 48.35%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on DLB shares. Wall Street Zen upgraded Dolby Laboratories from a "hold" rating to a "buy" rating in a research note on Friday, May 30th. Barrington Research restated an "outperform" rating and set a $100.00 target price on shares of Dolby Laboratories in a research note on Friday, May 2nd. Rosenblatt Securities restated a "buy" rating and set a $95.00 target price on shares of Dolby Laboratories in a research note on Friday. Finally, Tigress Financial started coverage on Dolby Laboratories in a research report on Thursday, May 15th. They issued a "buy" rating and a $112.00 price objective for the company.

Read Our Latest Stock Analysis on DLB

Insider Buying and Selling

In related news, CEO Kevin J. Yeaman sold 2,491 shares of the firm's stock in a transaction that occurred on Wednesday, July 16th. The stock was sold at an average price of $75.00, for a total transaction of $186,825.00. Following the completion of the transaction, the chief executive officer owned 114,725 shares in the company, valued at $8,604,375. This trade represents a 2.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Mark Andrew Sherman sold 15,000 shares of the firm's stock in a transaction that occurred on Wednesday, June 4th. The stock was sold at an average price of $75.02, for a total value of $1,125,300.00. Following the transaction, the executive vice president owned 62,397 shares of the company's stock, valued at $4,681,022.94. This trade represents a 19.38% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 116,049 shares of company stock valued at $8,713,391 in the last quarter. Corporate insiders own 38.39% of the company's stock.

Hedge Funds Weigh In On Dolby Laboratories

Several hedge funds and other institutional investors have recently modified their holdings of DLB. Royal Bank of Canada lifted its position in shares of Dolby Laboratories by 3.5% during the 1st quarter. Royal Bank of Canada now owns 68,367 shares of the electronics maker's stock worth $5,491,000 after buying an additional 2,298 shares during the period. Goldman Sachs Group Inc. increased its holdings in Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker's stock valued at $20,043,000 after purchasing an additional 171,288 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its holdings in Dolby Laboratories by 5.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 238,216 shares of the electronics maker's stock valued at $19,131,000 after purchasing an additional 12,598 shares in the last quarter. Finally, Focus Partners Wealth acquired a new stake in Dolby Laboratories during the 1st quarter valued at $390,000. Institutional investors own 58.56% of the company's stock.

Dolby Laboratories Company Profile

(Get Free Report)

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.

See Also

Earnings History and Estimates for Dolby Laboratories (NYSE:DLB)

Should You Invest $1,000 in Dolby Laboratories Right Now?

Before you consider Dolby Laboratories, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.

While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines